(Q43566895)

English

Capecitabine (Xeloda) improves medical resource use compared with 5-fluorouracil plus leucovorin in a phase III trial conducted in patients with advanced colorectal carcinoma.

scientific article published in March 2001

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11290435%20AND%20SRC:MED&resulttype=core&format=json

6 November 2019

Capecitabine (Xeloda) improves medical resource use compared with 5-fluorouracil plus leucovorin in a phase III trial conducted in patients with advanced colorectal carcinoma (English)

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11290435%20AND%20SRC:MED&resulttype=core&format=json

6 November 2019

phase III clinical trial

0 references

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

Michael J. Boyer

2

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11290435%20AND%20SRC:MED&resulttype=core&format=json

6 November 2019

author name string

C Twelves

1

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11290435%20AND%20SRC:MED&resulttype=core&format=json

6 November 2019

M Findlay

3

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11290435%20AND%20SRC:MED&resulttype=core&format=json

6 November 2019

J Cassidy

4

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11290435%20AND%20SRC:MED&resulttype=core&format=json

6 November 2019

C Weitzel

5

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11290435%20AND%20SRC:MED&resulttype=core&format=json

6 November 2019

C Barker

6

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11290435%20AND%20SRC:MED&resulttype=core&format=json

6 November 2019

B Osterwalder

7

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11290435%20AND%20SRC:MED&resulttype=core&format=json

6 November 2019

C Jamieson

8

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11290435%20AND%20SRC:MED&resulttype=core&format=json

6 November 2019

K Hieke

9

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11290435%20AND%20SRC:MED&resulttype=core&format=json

6 November 2019

Xeloda Colorectal Cancer Study Group

10

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11290435%20AND%20SRC:MED&resulttype=core&format=json

6 November 2019

language of work or name

1 reference

based on heuristic

inferred from title

publication date

1 March 2001

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11290435%20AND%20SRC:MED&resulttype=core&format=json

6 November 2019

European Journal of Cancer

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11290435%20AND%20SRC:MED&resulttype=core&format=json

6 November 2019

37

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11290435%20AND%20SRC:MED&resulttype=core&format=json

6 November 2019

5

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11290435%20AND%20SRC:MED&resulttype=core&format=json

6 November 2019

597-604

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11290435%20AND%20SRC:MED&resulttype=core&format=json

6 November 2019

Global cancer statistics

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2800%2900444-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Cancer statistics, 1999.

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2800%2900444-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Colorectal cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2800%2900444-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Worldwide patterns of cancer mortality, 1985-89.

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2800%2900444-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Adjuvant or palliative chemotherapy for colorectal cancer in patients 70 years or older.

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2800%2900444-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Chemotherapy for the treatment of patients with metastatic colorectal cancer: an overview

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2800%2900444-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Modulation of fluorouracil by leucovorin in patients with advanced colorectal cancer: evidence in terms of response rate. Advanced Colorectal Cancer Meta-Analysis Project

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2800%2900444-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Toxicity of fluorouracil in patients with advanced colorectal cancer: effect of administration schedule and prognostic factors.

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2800%2900444-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Development of treatment for advanced colorectal cancer: infusional 5-FU and the role of new agents

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2800%2900444-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Design of a novel oral fluoropyrimidine carbamate, capecitabine, which generates 5-fluorouracil selectively in tumours by enzymes concentrated in human liver and cancer tissue

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2800%2900444-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Preliminary studies of a novel oral fluoropyrimidine carbamate: capecitabine

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2800%2900444-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Preferential activation of capecitabine in tumor following oral administration to colorectal cancer patients

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2800%2900444-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Randomized comparison of two schedules of fluorouracil and leucovorin in the treatment of advanced colorectal cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2800%2900444-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Randomized trial comparing monthly low-dose leucovorin and fluorouracil bolus with bimonthly high-dose leucovorin and fluorouracil bolus plus continuous infusion for advanced colorectal cancer: a French intergroup study

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2800%2900444-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Cost of Treating Advanced Colorectal Cancer: A Retrospective Comparison of Treatment Regimens

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2800%2900444-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Patient preferences for oral versus intravenous palliative chemotherapy

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2800%2900444-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Oral fluoropyrimidines: a closer look at their toxicities

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2800%2900444-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1016/S0959-8049(00)00444-5

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11290435%20AND%20SRC:MED&resulttype=core&format=json

6 November 2019

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11290435%20AND%20SRC:MED&resulttype=core&format=json

6 November 2019

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q43566895&oldid=2146166206"